Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

NCT01629082 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

NIH

Sponsor class

Conditions

Myeldysplastic Syndrome (MDS)
Chronic Myelomonocytic Leukemia
Bone Marrow Diseases
Neutropenia
Acute Myeloid Leukemia (AML)

Interventions

DRUG: Clofarabine
DRUG: Lenalidomide

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]